Sarah Gross, Charlotte Vogtlander, Caitlin Lewis, Edward van Harmelen, Alexandra Stolzing, Norbert Radacsi
{"title":"Lipid- and Polymer-Based Nanoscale Delivery of Anti-Aging Phytochemicals.","authors":"Sarah Gross, Charlotte Vogtlander, Caitlin Lewis, Edward van Harmelen, Alexandra Stolzing, Norbert Radacsi","doi":"10.1002/wnan.70060","DOIUrl":null,"url":null,"abstract":"<p><p>Recently, nano-scale delivery approaches have been a field of focus to improve the limitations regarding current traditional delivery systems of phytochemicals to treat age-related disorders. Nanotechnology can help to overcome both the large and small-scale barriers associated with traditional drug and vitamin delivery techniques, such as poor biodistribution, instability, and intracellular trafficking, through cell-targeting and other methods. The main forms of nano-drug delivery systems can be classified under lipid-based nanocarrier systems, polymer-based nanocarrier systems, and inorganic carriers. This report focuses on the former two by presenting a comparative review of the advantages and disadvantages of each platform for the oral delivery of phytochemical-encapsulated drugs to treat age-related disorders. Nano-drug delivery systems were found to increase the anti-aging activities of curcumin, fisetin, quercetin, and astaxanthin. A variety of in vivo and in vitro studies show that nano-scale encapsulation methods have the potential to improve the delivery and bioactivity of anti-aging phytochemicals. This article is categorized under: Biology-Inspired Nanomaterials > Lipid-Based Structures Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.</p>","PeriodicalId":94267,"journal":{"name":"Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology","volume":"18 3","pages":"e70060"},"PeriodicalIF":8.2000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/wnan.70060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Recently, nano-scale delivery approaches have been a field of focus to improve the limitations regarding current traditional delivery systems of phytochemicals to treat age-related disorders. Nanotechnology can help to overcome both the large and small-scale barriers associated with traditional drug and vitamin delivery techniques, such as poor biodistribution, instability, and intracellular trafficking, through cell-targeting and other methods. The main forms of nano-drug delivery systems can be classified under lipid-based nanocarrier systems, polymer-based nanocarrier systems, and inorganic carriers. This report focuses on the former two by presenting a comparative review of the advantages and disadvantages of each platform for the oral delivery of phytochemical-encapsulated drugs to treat age-related disorders. Nano-drug delivery systems were found to increase the anti-aging activities of curcumin, fisetin, quercetin, and astaxanthin. A variety of in vivo and in vitro studies show that nano-scale encapsulation methods have the potential to improve the delivery and bioactivity of anti-aging phytochemicals. This article is categorized under: Biology-Inspired Nanomaterials > Lipid-Based Structures Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.